Veterinary Medicine Information website

Gallivac IBD S706 Neo šumivé tablety na suspenziu

Authorised
  • Infectious bursal disease virus, strain S706, Live

Product identification

Medicine name:
Gallivac IBD S706 Neo šumivé tablety na suspenziu
Active substance:
  • Infectious bursal disease virus, strain S706, Live
Target species:
  • Chicken (broiler)
  • Chicken (pullet for egg production, future layer)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain S706, Live
    4.00
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (broiler)
      • All relevant tissues
        0
        day
    • Chicken (pullet for egg production, future layer)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/004/20-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 12/08/2024